3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Tobacco & Marijuana -

Nicotine tablets help COPD patients quit smoking

Tobacco & MarijuanaAug 25, 06

Nicotine replacement therapy enables a significant number of patients with chronic obstructive pulmonary disease (COPD) to stop smoking, according to a report in the August issue of Chest.

“Nicotine replacement therapy works in COPD,” Dr. Philip Tønnesen from Gentofte Hospital, Hellerup, Denmark, told Reuters Health. “And nicotine replacement therapy works in smokers of fewer than 10 cigarettes per day. I believe this is the first study ever to show this.”

COPD is a group of serious lung diseases that include emphysema and chronic bronchitis. It is primarily caused by smoking.

Tønnesen and colleagues compared the efficacy of nicotine replacement combined with high- or low-behavioral support for smoking cessation in 370 patients with COPD who smoked an average of about 19 cigarettes daily.

The use of under-the-tongue nicotine tablets was associated with an approximate doubling of abstinence rates compared with placebo at 6 (23 percent versus 10 percent) and 12 months (17 percent versus 10 percent), respectively, the authors report.

However, the intensity of behavioral support did not significantly influence the outcomes.

“The good thing from our design is that both the interventions used seem to be effective,” Tønnesen said.

Neither nicotine replacement nor behavioral support significantly influenced smoking reduction among patients who continued to smoke after 6 or 12 months, the results indicate.

Smoking cessation was associated with a significant increase in lung function, the investigators say, whereas lung function remained stable among those who reduced their smoking but deteriorated among those who continued smoking at their baseline rate.

Adverse events occurred at similar rates in the nicotine and placebo groups and in the high- and low-behavioral support groups.

“We must get our COPD patients to quit smoking,” Tønnesen said, adding “smoking cessation should be an integral part of therapy for patients who smoke with respiratory disease.”

SOURCE: Chest, August 2006.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  Quitting smoking has favorable metabolic effects
  Opioid prescription is on the increase
  Could smoking pot raise testicular cancer risk?
  Popular kids in US and Mexico more likely to smoke, USC studies show
  Continued Smoking Can Spread Cancer
  Majority of fourth graders are exposed to smoke, study finds
  Republican Cain says ad not promoting smoking
  Fatal Crashes in the U.S.: Fewer Canadian Drivers Under The Influence
  Smoke from Southeast wildfires is health hazard
  Varenicline for smoking cessation linked to increased risk of serious harmful cardiac events
  Smoking in combination with immunosuppression poses greater risk for transplant-related carcinoma
  Study shows secondhand smoke a serious health threat to casino workers, patrons

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site